We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
56 hedge funds and large institutions have $558M invested in Rocket Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,639% more capital invested
Capital invested by funds: $32.1M → $558M (+$526M)
600% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 2
270% more call options, than puts
Call options by funds: $825K | Put options by funds: $223K
147% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 15
67.52% more ownership
Funds ownership: 11.01% → 78.53% (+68%)
65% more funds holding
Funds holding: 34 → 56 (+22)
Holders
56
Holders Change
+22
Holders Change %
+64.71%
% of All Funds
1.28%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
37
Increased
14
Reduced
2
Closed
15
Calls
$825K
Puts
$223K
Net Calls
+$602K
Net Calls Change
+$521K
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$244M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$48.4M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
+$28M |
| 4 |
BM
Bridger Management
New York
|
+$25.7M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$24.8M |
Top Sellers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.7M |
| 2 |
Jennison Associates
New York
|
-$3.57M |
| 3 |
SAM
Senzar Asset Management
New York
|
-$1.66M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.4M |
| 5 |
JP Morgan Chase
New York
|
-$147K |
